Sartorius Stedim Biotech Stock Probability of Future Pink Sheet Price Finishing Over 232.33
| SDMHF Stock | USD 176.10 1.90 1.07% |
Sartorius |
Sartorius Stedim Target Price Odds to finish over 232.33
The tendency of Sartorius Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 232.33 or more in 90 days |
| 176.10 | 90 days | 232.33 | near 1 |
Based on a normal probability distribution, the odds of Sartorius Stedim to move over $ 232.33 or more in 90 days from now is near 1 (This Sartorius Stedim Biotech probability density function shows the probability of Sartorius Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Sartorius Stedim Biotech price to stay between its current price of $ 176.10 and $ 232.33 at the end of the 90-day period is about 98.0 .
Assuming the 90 days horizon Sartorius Stedim has a beta of 0.6. This usually implies as returns on the market go up, Sartorius Stedim average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Sartorius Stedim Biotech will be expected to be much smaller as well. Additionally Sartorius Stedim Biotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Sartorius Stedim Price Density |
| Price |
Predictive Modules for Sartorius Stedim
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sartorius Stedim Biotech. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sartorius Stedim Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Sartorius Stedim is not an exception. The market had few large corrections towards the Sartorius Stedim's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sartorius Stedim Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sartorius Stedim within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.15 | |
β | Beta against Dow Jones | 0.60 | |
σ | Overall volatility | 11.07 | |
Ir | Information ratio | -0.06 |
Sartorius Stedim Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sartorius Stedim for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sartorius Stedim Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Sartorius Stedim generated a negative expected return over the last 90 days | |
| Sartorius Stedim has high historical volatility and very poor performance | |
| About 74.0% of the company outstanding shares are owned by corporate insiders |
Sartorius Stedim Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sartorius Pink Sheet often depends not only on the future outlook of the current and potential Sartorius Stedim's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sartorius Stedim's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 92.2 M |
Sartorius Stedim Technical Analysis
Sartorius Stedim's future price can be derived by breaking down and analyzing its technical indicators over time. Sartorius Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sartorius Stedim Biotech. In general, you should focus on analyzing Sartorius Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Sartorius Stedim Predictive Forecast Models
Sartorius Stedim's time-series forecasting models is one of many Sartorius Stedim's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sartorius Stedim's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Sartorius Stedim Biotech
Checking the ongoing alerts about Sartorius Stedim for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sartorius Stedim Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Sartorius Stedim generated a negative expected return over the last 90 days | |
| Sartorius Stedim has high historical volatility and very poor performance | |
| About 74.0% of the company outstanding shares are owned by corporate insiders |
Other Information on Investing in Sartorius Pink Sheet
Sartorius Stedim financial ratios help investors to determine whether Sartorius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Stedim security.